abstract |
Disclosed are novel calcium release-activated calcium (CRAC) channel inhibitors, methods for their preparation, pharmaceutical compositions containing them, and methods of treatment therewith. The present disclosure also relates to methods of treating non-small cell lung cancer (NSCLC) using CRAC inhibitors and methods of identifying cancer therapies and diagnostic therapies. |